Related Experiment Video
Updated: Jun 25, 2026

06:17
Depletion of Specific Cell Populations by Complement Depletion
Published on: February 5, 2010
Coagulation-factor deficiencies and abnormal bleeding in Noonan's syndrome
M Sharland1, M A Patton, S Talbot
1South West Thames Regional Genetics Service, St George's Hospital Medical School, London, UK.
Lancet (London, England)
|January 4, 1992
Summary
Noonan syndrome patients often experience bleeding issues due to intrinsic coagulation pathway defects. These bleeding disorders, including factor deficiencies, suggest an autosomal genetic link in Noonan syndrome.
Area of Science:
- Genetics
- Hematology
- Pediatrics
Background:
- Noonan syndrome is an autosomal dominant disorder.
- Key features include dysmorphic facies, congenital heart disease, and short stature.
- Abnormal bleeding has been anecdotally reported in patients.
Purpose of the Study:
- To investigate coagulation-factor deficits in individuals with Noonan syndrome.
- To determine the prevalence and nature of bleeding abnormalities.
- To explore the genetic basis of bleeding tendencies in this condition.
Main Methods:
- Studied 72 individuals (37 male, 35 female) with Noonan syndrome.
- Assessed history of abnormal bruising or bleeding.
- Performed coagulation tests, including activated partial thromboplastin time.
- Identified specific coagulation factor deficiencies in the intrinsic pathway.
Main Results:
- 65% of patients reported abnormal bleeding history.
- 40% exhibited prolonged activated partial thromboplastin time.
- 50% had deficiencies in intrinsic pathway factors (XI, XII, VIII).
- Poor correlation observed between bleeding history and factor deficits.
- Similar coagulation defects found in relatives with Noonan syndrome.
Conclusions:
- Noonan syndrome is associated with intrinsic pathway coagulation factor deficiencies.
- These bleeding abnormalities suggest autosomal regulation of the coagulation cascade.
- Further research is warranted to elucidate the genetic mechanisms involved.
Related Concept Videos
Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...

